0100sek
1,8 %
Date:2025-05-15Time:11:13:56Latest report:Q4-2024List:First NorthTicker:LPGO
Market Cap:15 msekEnterprise Value:3 msekNet Sales:10,3 msekEarnings:-25,3 msekEmployees:0ISIN:SE0015382072

Ratios

10-year key figure history for Lipigon Pharmaceuticals turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Lipigon Pharmaceuticals with index and moving average MA50 and MA200.

Stockprice:0,100
MA50:0,15
MA200:0,19
Price/MA200:-47,3 %
RSI (14):47,9
Price/MA50:-31,6 %

Description

Lipigon Pharmaceuticals operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and includes drugs for rare diseases. These are mainly treatments for diseases caused by disorders in the body's handling of fats. In addition to the main business, service and associated ancillary services are also offered. Lipigon Pharmaceuticals operates worldwide, with the largest presence in the Nordic market.

Pharmaceuticals